WO2002061037B1 - Administration d'une sequence d'acides amines a un animal femelle - Google Patents

Administration d'une sequence d'acides amines a un animal femelle

Info

Publication number
WO2002061037B1
WO2002061037B1 PCT/US2001/048726 US0148726W WO02061037B1 WO 2002061037 B1 WO2002061037 B1 WO 2002061037B1 US 0148726 W US0148726 W US 0148726W WO 02061037 B1 WO02061037 B1 WO 02061037B1
Authority
WO
WIPO (PCT)
Prior art keywords
vector
animal
female
cells
offspring
Prior art date
Application number
PCT/US2001/048726
Other languages
English (en)
Other versions
WO2002061037A3 (fr
WO2002061037A2 (fr
Inventor
Robert J Schwartz
Robert H Carpenter
Ruxandra Draghia-Akli
Douglas R Kern
Roy G Smith
Original Assignee
Baylor College Medicine
Advisys Inc
Robert J Schwartz
Robert H Carpenter
Ruxandra Draghia-Akli
Douglas R Kern
Roy G Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine, Advisys Inc, Robert J Schwartz, Robert H Carpenter, Ruxandra Draghia-Akli, Douglas R Kern, Roy G Smith filed Critical Baylor College Medicine
Priority to EP01997073A priority Critical patent/EP1364004A4/fr
Priority to AU2002248194A priority patent/AU2002248194B2/en
Priority to BR0116472-4A priority patent/BR0116472A/pt
Priority to CA2430921A priority patent/CA2430921C/fr
Priority to MXPA03005236A priority patent/MXPA03005236A/es
Priority to KR10-2003-7007872A priority patent/KR20040039187A/ko
Publication of WO2002061037A2 publication Critical patent/WO2002061037A2/fr
Publication of WO2002061037A3 publication Critical patent/WO2002061037A3/fr
Publication of WO2002061037B1 publication Critical patent/WO2002061037B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0271Chimeric vertebrates, e.g. comprising exogenous cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/02Animal zootechnically ameliorated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/15Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La croissance est améliorée au moyen d'une technique d'amélioration du potentiel de la croissance, laquelle technique consiste à administrer une séquence d'acides aminés, telle que GHRH ou un analogue, à un animal femelle, de préférence par administration par voie parentérale. Les porcelets nés de truies auxquelles on a injecté un ADN codant pour GHRH, sont plus gros. Ces effets sont démontrés lors de gestations ultérieures sans administration(s) supplémentaire(s) du vecteur.
PCT/US2001/048726 2000-12-12 2001-12-12 Administration d'une sequence d'acides amines a un animal femelle WO2002061037A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP01997073A EP1364004A4 (fr) 2000-12-12 2001-12-12 Administration d'une sequence d'acides amines a un animal femelle
AU2002248194A AU2002248194B2 (en) 2000-12-12 2001-12-12 Administration of nucleic acid sequence to female animal
BR0116472-4A BR0116472A (pt) 2000-12-12 2001-12-12 Administração de sequência de ácido nucléico a animal fêmea para aumentar o crescimento de prole
CA2430921A CA2430921C (fr) 2000-12-12 2001-12-12 Utilisation d'un vecteur codant pour un peptide de ghrh destine a ameliorer la croissance dans de multiples portees de la progeniture d'animaux femelles
MXPA03005236A MXPA03005236A (es) 2000-12-12 2001-12-12 Administracion de secuencia de acido nucleico a un animal hembra para mejorar el crecimiento en la progenie.
KR10-2003-7007872A KR20040039187A (ko) 2000-12-12 2001-12-12 암컷 동물에 핵산 서열의 투여

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25502100P 2000-12-12 2000-12-12
US60/255,021 2000-12-12

Publications (3)

Publication Number Publication Date
WO2002061037A2 WO2002061037A2 (fr) 2002-08-08
WO2002061037A3 WO2002061037A3 (fr) 2003-10-02
WO2002061037B1 true WO2002061037B1 (fr) 2004-01-15

Family

ID=22966509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048726 WO2002061037A2 (fr) 2000-12-12 2001-12-12 Administration d'une sequence d'acides amines a un animal femelle

Country Status (10)

Country Link
EP (1) EP1364004A4 (fr)
KR (1) KR20040039187A (fr)
CN (1) CN1575301A (fr)
AR (1) AR035671A1 (fr)
AU (1) AU2002248194B2 (fr)
BR (1) BR0116472A (fr)
CA (1) CA2430921C (fr)
MX (1) MXPA03005236A (fr)
PL (1) PL366116A1 (fr)
WO (1) WO2002061037A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0213965A (pt) 2001-10-26 2005-03-15 Baylor College Medicine Composição e método para alterar as propriedades de massa corporal magra e ósseas em um indivìduo
EP1499731B1 (fr) * 2002-02-07 2011-05-25 Baylor College Of Medicine Developpement modifie de l'hypophyse chez la progeniture de femelles animales portantes traitees par la therapie hormonale de liberation de l'hormone de croissance
US7316925B2 (en) 2002-07-16 2008-01-08 Vgx Pharmaceuticals, Inc. Codon optimized synthetic plasmids
DE10240418A1 (de) * 2002-09-02 2004-03-11 Avontec Gmbh Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen
US20040175727A1 (en) * 2002-11-04 2004-09-09 Advisys, Inc. Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
CA2513743C (fr) * 2003-01-28 2013-06-25 Advisys, Inc. Reduction de reforme dans l'hormone de croissance (ghrh) d'animaux de troupeau
CN102127545A (zh) * 2010-11-24 2011-07-20 山东农业大学 一种骨骼肌特异性ckm启动子及其应用
CN104031930B (zh) * 2014-05-30 2017-09-22 华南农业大学 一种提高母猪乳中营养及免疫物质含量的方法
CN105219774B (zh) * 2015-10-10 2019-04-30 广西大学 猪胰岛素特异性表达启动子pip2及其应用
CN105617404A (zh) * 2016-01-27 2016-06-01 广州市科虎生物技术研究开发中心 Grf表达质粒在制备降低仔猪出生弱仔率的药物中的用途
DE202018105142U1 (de) * 2018-04-29 2018-10-08 Kalmarna Limited - CCS Trustees Limited Zusammensetzungen zur oralen Verabreichung zum Beeinflussen der Nachkommenschaft von Säugetieren
CN115044666B (zh) * 2022-06-13 2024-06-25 天津市农业科学院 一种用于预测母猪二胎综合征的snp分子标记及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
CA2085362A1 (fr) * 1990-06-29 1991-12-30 Arthur M. Felix Analogues d'un facteur liberant de l'hormone de croissance substituee par l'histidine
US6165755A (en) * 1997-01-23 2000-12-26 University Of Victoria Innovation And Development Corporation Chicken neuropeptide gene useful for improved poultry production
EP0988388A2 (fr) * 1997-07-24 2000-03-29 Valentis Inc. Systeme d'expression de ghrh et procedes d'utilisation
DE60023906T2 (de) * 1999-07-26 2006-07-20 Baylor College Of Medicine, Houston Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein

Also Published As

Publication number Publication date
AU2002248194B2 (en) 2007-04-05
CA2430921C (fr) 2016-06-07
WO2002061037A3 (fr) 2003-10-02
PL366116A1 (en) 2005-01-24
KR20040039187A (ko) 2004-05-10
CN1575301A (zh) 2005-02-02
AR035671A1 (es) 2004-06-23
CA2430921A1 (fr) 2002-08-08
MXPA03005236A (es) 2005-04-08
EP1364004A4 (fr) 2005-11-09
BR0116472A (pt) 2005-04-05
WO2002061037A2 (fr) 2002-08-08
EP1364004A2 (fr) 2003-11-26

Similar Documents

Publication Publication Date Title
WO2002061037B1 (fr) Administration d'une sequence d'acides amines a un animal femelle
US5037806A (en) Biologically active method using somatotropins
CN102399283B (zh) 水貂生长激素释放激素cDNA及其应用
CA2378943A1 (fr) Analogue superactif de la somatostatine porcine
CN102399284B (zh) 狐狸生长激素释放激素cDNA及其应用
CZ282867B6 (cs) Expresní vektory pro zvýšenou produkci polypeptidů, plasmidy obsahující tyto vektory, hostitelé obsahující tyto plasmidy, získané produkty a související způsoby
CN107050434A (zh) 包含重组hcg的药物制剂
US20230357345A1 (en) Glycoprotein Hormone Long-Acting Superagonists
Mao et al. Ontogeny of growth hormone receptor gene expression in tissue of growth-selected strains of broiler chickens
CA2513743A1 (fr) Reduction de reforme dans l'hormone de croissance (ghrh) d'animaux de troupeau
Khan et al. Effects of maternal plasmid GHRH treatment on offspring growth
Wray-Cahen et al. Redefining body composition: nutrients, hormones, and genes in meat production
Bai et al. Effects of immunization against a DNA vaccine encoding somatostatin gene (pGM-CSF/SS) by attenuated Salmonella typhimurium on growth, reproduction and lactation in female mice
Guillaumot et al. Prolactin receptors are expressed and hormonally regulated in rat Sertoli cells
EP1218508B1 (fr) Séquences d'ADN pour accroître l'efficacité de l'alimentation et la vitesse de croissance des porcins
RU2034457C1 (ru) Способ повышения продуктивности сельскохозяйственных животных и препарат для его осуществления
Dunaiski et al. Effect of growth hormone administration on IGF binding protein-3 mRNA levels in porcine tissues
CN104789514B (zh) 一种生长抑制素超表达dna疫苗及构建方法和应用
Etherton Emerging strategies for enhancing growth: is there a biotechnology better than somatotropin?
Duittoz et al. The Horse: An Unexpected Animal Model for (Unexpected) Neuroendocrinology
Armstrong et al. The application of biotechnology for future livestock production
SHORT MRC Unit of Reproductive Biology, Edinburgh
Hansel Prospective developments in animal agriculture
AU647374B2 (en) Sheep growth hormone
CN118271466A (zh) 一种重组鱼GtH融合蛋白及其制备方法与应用

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 01822008.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2430921

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020037007872

Country of ref document: KR

Ref document number: PA/a/2003/005236

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2002248194

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 526621

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2001997073

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1-2003-500503

Country of ref document: PH

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001997073

Country of ref document: EP

B Later publication of amended claims

Effective date: 20031013

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 1020037007872

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP

WWG Wipo information: grant in national office

Ref document number: 2002248194

Country of ref document: AU